During the past decade, SwedishAmerican Regional Cancer Center/ACT conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 80 clinical trials were completed, i.e. on average, 181.8% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 40 clinical trials were completed. i.e. 285.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SwedishAmerican Regional Cancer Center/ACT" #1 sponsor was "National Cancer Institute (NCI)" with 59 trials, followed by "Eastern Cooperative Oncology Group" with 20 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored, "SWOG Cancer Research Network" with 14 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SwedishAmerican Regional Cancer Center/ACT" #1 collaborator was "National Cancer Institute (NCI)" with 86 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "SwedishAmerican Regional Cancer Center/ACT" are "Breast Cancer" (16 trials), "Lung Cancer" (11 trials), "Lymphoma" (7 trials), "Prostate Cancer" (6 trials) and "Stage IV Cutaneous Melanoma AJCC v6 and v7" (6 trials). Many other conditions were trialed in "SwedishAmerican Regional Cancer Center/ACT" in a lesser frequency.

Most popular intervention types in "SwedishAmerican Regional Cancer Center/ACT" are "Drug" (124 trials), "Other" (70 trials), "Biological" (66 trials), "Radiation" (37 trials) and "Procedure" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (36 trials), "Quality-of-Life Assessment" (22 trials), "Cisplatin" (19 trials), "Carboplatin" (16 trials) and "Paclitaxel" (15 trials). Other intervention names were less common.

The vast majority of trials in "SwedishAmerican Regional Cancer Center/ACT" are 123 trials for "All" genders, 20 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "SwedishAmerican Regional Cancer Center/ACT". undefined are not yet recruiting, 16 are recruiting, 62 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in SwedishAmerican Regional Cancer Center/ACT, 2 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in SwedishAmerican Regional Cancer Center/ACT, 1 "Phase 1" clinical trials were conducted, 61 "Phase 2" clinical trials and 90 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".